HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pattaraporn Vanachayangkul Selected Research

Chemoprevention

10/2014Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pattaraporn Vanachayangkul Research Topics

Disease

9Malaria
07/2020 - 11/2012
6Infections
01/2022 - 01/2014
3Body Weight (Weight, Body)
01/2020 - 11/2012
2Parasitemia
01/2020 - 11/2012
2Falciparum Malaria (Plasmodium falciparum Malaria)
06/2015 - 11/2012
2Vivax Malaria
12/2014 - 01/2014
1COVID-19
01/2020
1Wounds and Injuries (Trauma)
01/2012
1Renal Insufficiency (Renal Failure)
01/2012

Drug/Important Bio-Agent (IBA)

4PrimaquineFDA Link
01/2022 - 01/2014
4Pharmaceutical PreparationsIBA
07/2020 - 11/2012
4artenimol (dihydroartemisinin)IBA
01/2017 - 01/2014
4piperaquineIBA
01/2017 - 01/2014
3Chloroquine (Aralen)FDA LinkGeneric
07/2020 - 12/2014
2ArtesunateIBA
09/2019 - 11/2012
2Antimalarials (Antimalarial Agents)IBA
01/2017 - 06/2015
2artemisinin (artemisinine)IBA
06/2015 - 11/2012
1plasmepsin (plasmepsin I)IBA
07/2020
1Exonucleases (3' 5' Exonuclease)IBA
07/2020
1Genetic Markers (Genetic Marker)IBA
07/2020
1Ivermectin (Mectizan)FDA Link
01/2020
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
01/2020
1MMV390048IBA
01/2017
1alpha-aminopyridineIBA
01/2017
1VaccinesIBA
01/2017
1melamineIBA
01/2012

Therapy/Procedure

3Therapeutics
01/2020 - 06/2015
1AP protocol 1
09/2019
1Complementary Therapies (Alternative Medicine)
01/2017
1Chemoprevention
10/2014